0

Pharmacy benefit managers: a mechanism for containing costs or a contributor to rising drug prices?

While pharmaceutical companies are often the focus of conversations about high drug prices, more recently pharmacy benefit managers (PBMs) have come under increased drug price scrutiny. The American PBM business model, developed in the early 2000s, was designed to identify… Continue Reading

0

Who Are the Real Change-Agents in Pharma Market Access? The Growing Role of Value Demonstration

Would you believe it if I said that in a few years, the term “HEOR” may go the way of man-buns and flip phones? While the man-bun joke about the terminology may be a slight exaggeration, our field is indeed undergoing… Continue Reading

0

Big Ideas for Big Data Analytics in Real-World Evidence: Insights from Dr. Rich Gliklich, CEO of OM1

  Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Dr. Rich Gliklich, CEO of OM1, to discuss how big data analytics are changing the face of real world evidence (RWE). The mission of this Cambridge, Massachusetts digital health company… Continue Reading

0

How Much Do HEOR Professionals Make?

I wish the buck stopped here. I could use a few.  That sounds a little like a Henny Youngman one-liner, doesn’t it? Could you use a few more bucks?  Do you know if your salary is fair or can you… Continue Reading

0

SPLAT! How HEOR Communication Tools Fall Flat With Your Customers – But Don’t Have To!

Publication: It’s the last step of the research process. But, do you put as much effort into the quality of your HEOR Publications and Communication Tools as you did on the design and implementation of your research? Did your communication… Continue Reading